about
A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomesCorrelates of age at attainment of developmental milestones in HIV-infected infants receiving early antiretroviral therapy.High mortality in HIV-infected children diagnosed in hospital underscores need for faster diagnostic turnaround time in prevention of mother-to-child transmission of HIV (PMTCT) programsNevirapine Resistance in Previously Nevirapine-Unexposed HIV-1-Infected Kenyan Infants Initiating Early Antiretroviral Therapy.Younger age at HAART initiation is associated with more rapid growth reconstitution.Low-frequency nevirapine resistance at multiple sites may predict treatment failure in infants on nevirapine-based treatment.Knowing a sexual partner is HIV-1-uninfected is associated with higher condom use among HIV-1-infected adults in Kenya.Comparison of developmental milestone attainment in early treated HIV-infected infants versus HIV-unexposed infants: a prospective cohort study.Hospitalized Children Reveal Health Systems Gaps in the Mother-Child HIV Care Cascade in KenyaLong-term virologic response and genotypic resistance mutations in HIV-1 infected Kenyan children on combination antiretroviral therapy.Lipid changes in Kenyan HIV-1-infected infants initiating highly active antiretroviral therapy by 1 year of ageSurvival benefit of early infant antiretroviral therapy is compromised when diagnosis is delayed.Accelerated suppression of primary Epstein-Barr virus infection in HIV-infected infants initiating lopinavir/ritonavir-based versus nevirapine-based combination antiretroviral therapy.High Viremia and Wasting Before Antiretroviral Therapy Are Associated With Pneumonia in Early-Treated HIV-Infected Kenyan Infants.Treatment interruption after 2-year antiretroviral treatment initiated during acute/early HIV in infancy.Infant/child rapid serology tests fail to reliably assess HIV exposure among sick hospitalized infants.Differences in virologic and immunologic response to antiretroviral therapy among HIV-1-infected infants and children.Urgent versus post-stabilisation antiretroviral treatment in hospitalised HIV-infected children in Kenya (PUSH): a randomised controlled trial.Implications of Combined Exposure to Household Air Pollution and HIV on Neurocognition in Children.Decay of HIV DNA in the Reservoir and the Impact of Short Treatment Interruption in Kenyan Infants.Improved Neurodevelopment Following Antiretroviral Therapy in HIV-Infected Children.
P50
Q28477310-E2FD49C0-4025-4B2B-96DE-6ADED86C2626Q35106962-8DDD5E0E-B40B-4F1E-92B1-6FBBB2DDC36DQ35176855-D007EBB9-D649-4A9E-A6E9-CBFA75AA6D72Q35942341-86160FD1-F768-4128-AE14-D776A52BE5BAQ36049040-9F651F61-C362-475C-A188-B90CEA1DCF42Q36060517-23803EDA-B437-48FB-9A6D-6F857EF5E3D4Q36116274-CA149A4D-3DDE-4387-AECD-1B6F9785540CQ36251762-A11D9277-B30D-4F9D-84AD-44269D095552Q36661488-E416D823-A8F9-47B9-98E8-7A11983E1680Q36673503-767034DA-6376-477E-AFAF-4E29D92EB7E5Q37080086-1EACB221-17B5-4144-A1A1-C01464B9FB1FQ37131384-7C478D56-8AF5-4234-BF68-228D0BBB3AC2Q37696585-C1642010-3701-4051-AA32-EB034CD3BD8FQ39535039-AC08DF69-74BE-4415-A528-D0391E4378FBQ39768190-21977EEB-8C2E-4EE8-9CCB-542A6CF6703EQ40161861-2F6BEA3C-EA8A-441D-84B3-87ECDFA70B86Q40548877-DF4ED561-DB5F-4009-839B-FF6E8922891AQ46460039-3E9D4C0A-735D-4C61-AE2C-E604845DB9E3Q48182789-7B6E24DD-88F1-4407-A893-DEA0B2B17C25Q49888173-D655449D-5615-4A65-B519-9258D20CBC24Q50042626-83C61BA6-5C4D-485A-AF92-E347CBC3A5A5
P50
name
Sarah Benki-Nugent
@ast
Sarah Benki-Nugent
@en
Sarah Benki-Nugent
@es
Sarah Benki-Nugent
@nl
type
label
Sarah Benki-Nugent
@ast
Sarah Benki-Nugent
@en
Sarah Benki-Nugent
@es
Sarah Benki-Nugent
@nl
prefLabel
Sarah Benki-Nugent
@ast
Sarah Benki-Nugent
@en
Sarah Benki-Nugent
@es
Sarah Benki-Nugent
@nl